Ibrutinib Plus Venetoclax in Subjects With Treatment-naive Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (CLL/SLL)
Clinical trial NCT02910583 · COMPLETED
Trial details
- NCT number
- NCT02910583
- Sponsor
- Pharmacyclics LLC.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-28
- Primary completion
- 2020-11-12
- Enrollment
- 323
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.